Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sayda M Elbashir

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Science Translational Medicine|April 30, 2025
Inclusion of a retroviral protease enhances the immunogenicity of VLP-forming mRNA vaccines against HIV-1 or SARS-CoV-2 in micePeng Zhang, Mamta Singh, Vada A Becker, et al.
Biorxiv : the Preprint Server for Biology|February 16, 2022
Boosting with Omicron-matched or historical mRNA vaccines increases neutralizing antibody responses and protection against B.1.1.529 infection in miceBaoling Ying, Suzanne M Scheaffer, Bradley Whitener, et al.
Science Translational Medicine|November 30, 2021
Protective activity of mRNA vaccines against ancestral and variant SARS-CoV-2 strainsBaoling Ying, Bradley Whitener, Laura A VanBlargan, et al.
Nature|May 15, 2024
Imprinting of serum neutralizing antibodies by Wuhan-1 mRNA vaccinesChieh-Yu Liang, Saravanan Raju, Zhuoming Liu, et al.
Biorxiv : the Preprint Server for Biology|October 20, 2022
Bivalent SARS-CoV-2 mRNA vaccines increase breadth of neutralization and protect against the BA.5 Omicron variantSuzanne M Scheaffer, Diana Lee, Bradley Whitener, et al.
Nature Medicine|October 20, 2022
Bivalent SARS-CoV-2 mRNA vaccines increase breadth of neutralization and protect against the BA.5 Omicron variant in miceSuzanne M Scheaffer, Diana Lee, Bradley Whitener, et al.
Science Translational Medicine|September 13, 2023
Domain-based mRNA vaccines encoding spike protein N-terminal and receptor binding domains confer protection against SARS-CoV-2Guillaume B E Stewart-Jones, Sayda M Elbashir, Kai Wu, et al.
Biorxiv : the Preprint Server for Biology|October 14, 2022
Development of SARS-CoV-2 mRNA vaccines encoding spike N-terminal and receptor binding domainsGuillaume B E Stewart-Jones, Sayda M Elbashir, Kai Wu, et al.
Cell|April 22, 2022
Boosting with variant-matched or historical mRNA vaccines protects against Omicron infection in miceBaoling Ying, Suzanne M Scheaffer, Bradley Whitener, et al.
Nature Medicine|December 10, 2021
A multiclade env-gag VLP mRNA vaccine elicits tier-2 HIV-1-neutralizing antibodies and reduces the risk of heterologous SHIV infection in macaquesPeng Zhang, Elisabeth Narayanan, Qingbo Liu, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Science Translational Medicine|April 30, 2025
Inclusion of a retroviral protease enhances the immunogenicity of VLP-forming mRNA vaccines against HIV-1 or SARS-CoV-2 in micePeng Zhang, Mamta Singh, Vada A Becker, et al.
Biorxiv : the Preprint Server for Biology|February 16, 2022
Boosting with Omicron-matched or historical mRNA vaccines increases neutralizing antibody responses and protection against B.1.1.529 infection in miceBaoling Ying, Suzanne M Scheaffer, Bradley Whitener, et al.
Science Translational Medicine|November 30, 2021
Protective activity of mRNA vaccines against ancestral and variant SARS-CoV-2 strainsBaoling Ying, Bradley Whitener, Laura A VanBlargan, et al.
Nature|May 15, 2024
Imprinting of serum neutralizing antibodies by Wuhan-1 mRNA vaccinesChieh-Yu Liang, Saravanan Raju, Zhuoming Liu, et al.
Biorxiv : the Preprint Server for Biology|October 20, 2022
Bivalent SARS-CoV-2 mRNA vaccines increase breadth of neutralization and protect against the BA.5 Omicron variantSuzanne M Scheaffer, Diana Lee, Bradley Whitener, et al.
Nature Medicine|October 20, 2022
Bivalent SARS-CoV-2 mRNA vaccines increase breadth of neutralization and protect against the BA.5 Omicron variant in miceSuzanne M Scheaffer, Diana Lee, Bradley Whitener, et al.
Science Translational Medicine|September 13, 2023
Domain-based mRNA vaccines encoding spike protein N-terminal and receptor binding domains confer protection against SARS-CoV-2Guillaume B E Stewart-Jones, Sayda M Elbashir, Kai Wu, et al.
Biorxiv : the Preprint Server for Biology|October 14, 2022
Development of SARS-CoV-2 mRNA vaccines encoding spike N-terminal and receptor binding domainsGuillaume B E Stewart-Jones, Sayda M Elbashir, Kai Wu, et al.
Cell|April 22, 2022
Boosting with variant-matched or historical mRNA vaccines protects against Omicron infection in miceBaoling Ying, Suzanne M Scheaffer, Bradley Whitener, et al.
Nature Medicine|December 10, 2021
A multiclade env-gag VLP mRNA vaccine elicits tier-2 HIV-1-neutralizing antibodies and reduces the risk of heterologous SHIV infection in macaquesPeng Zhang, Elisabeth Narayanan, Qingbo Liu, et al.
Pageof 3